MG 111 5-Trifluoromethyl-2'-deoxyuridine, [2-13C-1,3-15N2, 99 atom % 13C, 99 atom % 15N]- |
|
| Click here for Typical Certificate of Analysis | |
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram | |
| 1 mg $615 | |
| Screw cap v-vial - shipped on dry ice | 5 mg $1930 |
| M.W. 299.18 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 1134 5-Trifluoromethyl-2'-deoxyuridine, [2-14C]- |
|
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 100 µCi/ml | |
| > 40 mCi(1.48 GBq)/mmol | 10 µCi (370 kBq) $1240 |
| NextGen V-Vial - shipped on dry ice | 50 µCi (1.85 MBq) $3970 |
| M.W. 296.2 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 751 5-Trifluoromethyl-2'-deoxyuridine, [2'-3H]- |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol solution, 1 mCi/ml | |
| > 5 Ci(185 GBq)/mmol | 50 μCi (1.85 MBq) $1160 |
| NextGen V-Vial - shipped on dry ice | 250 μCi (9.25 MBq) $1970 |
| M.W. 296.2 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1503 5-Trifluoromethyl-2'-deoxyuridine, [6-3H]- |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol solution, 1 mCi/ml | |
| ≥ 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 296.2 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |